Growth Metrics

Integra Lifesciences Holdings (IART) Deferred Taxes (2016 - 2026)

Integra Lifesciences Holdings' Deferred Taxes history spans 17 years, with the latest figure at -$10.9 million for Q4 2025.

  • On a quarterly basis, Deferred Taxes fell 56.67% to -$10.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$66.3 million, a 219.64% decrease, with the full-year FY2025 number at -$66.3 million, down 219.64% from a year prior.
  • Deferred Taxes hit -$10.9 million in Q4 2025 for Integra Lifesciences Holdings, down from -$8.7 million in the prior quarter.
  • Over the last five years, Deferred Taxes for IART hit a ceiling of $10.7 million in Q4 2021 and a floor of -$44.8 million in Q2 2025.
  • Historically, Deferred Taxes has averaged -$5.3 million across 5 years, with a median of -$3.3 million in 2021.
  • Biggest five-year swings in Deferred Taxes: surged 387.2% in 2022 and later tumbled 2331.18% in 2025.
  • Tracing IART's Deferred Taxes over 5 years: stood at $10.7 million in 2021, then plummeted by 156.07% to -$6.0 million in 2022, then plummeted by 146.48% to -$14.8 million in 2023, then surged by 52.94% to -$7.0 million in 2024, then tumbled by 56.67% to -$10.9 million in 2025.
  • Business Quant data shows Deferred Taxes for IART at -$10.9 million in Q4 2025, -$8.7 million in Q3 2025, and -$44.8 million in Q2 2025.